Bioton SA banner
B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 4.16 PLN -0.95% Market Closed
Market Cap: zł357.2m

Bioton SA
Intangible Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Bioton SA
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
B
Bioton SA
WSE:BIO
Intangible Assets
zł327.1m
CAGR 3-Years
-3%
CAGR 5-Years
-3%
CAGR 10-Years
-12%
M
Mabion SA
WSE:MAB
Intangible Assets
zł184k
CAGR 3-Years
-38%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
R
Read Gene SA
WSE:RDG
Intangible Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
Pure Biologics SA
WSE:PUR
Intangible Assets
zł47k
CAGR 3-Years
-56%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
U
Urteste SA
WSE:URT
Intangible Assets
zł8.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Synthaverse SA
WSE:SVE
Intangible Assets
zł3.4m
CAGR 3-Years
124%
CAGR 5-Years
37%
CAGR 10-Years
-15%
No Stocks Found

Bioton SA
Glance View

Market Cap
357.2m PLN
Industry
Biotechnology

BIOTON SA engages in the manufacture and production of medicine and pharmaceutical substances. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 371 full-time employees. The company went IPO on 2005-03-16. The firm is engaged in research, development and wholesale trade of pharmaceutical and biotechnological products. The firm's portfolio consists of oral hypoglycemic drugs (metformin and glimepride) as well as recombinant human insulin in pharmaceutical substance form and for injections. Additionally, the Company provides advertising services. As of December 31, 2011, the Company formed a capital group and operated through its subsidiaries, including BIOTON TRADE Sp. z o.o., Mindar Holdings Ltd, Germonta Holdings Ltd, Tricel SA, SciGen Ltd and BioPartners Holdings AG, among others. On June 12, 2014, it sold a 50% stake in Copernicus Sp. z o.o.

BIO Intrinsic Value
5.78 PLN
Undervaluation 28%
Intrinsic Value
Price zł4.16
B

See Also

What is Bioton SA's Intangible Assets?
Intangible Assets
327.1m PLN

Based on the financial report for Dec 31, 2025, Bioton SA's Intangible Assets amounts to 327.1m PLN.

What is Bioton SA's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
-12%

Over the last year, the Intangible Assets growth was -3%. The average annual Intangible Assets growth rates for Bioton SA have been -3% over the past three years , -3% over the past five years , and -12% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett